UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties

Acta biomaterialia, 2019-01, Vol.84, p.317-327

2019

Volltextzugriff (PDF)

Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection

Acta biomaterialia, 2018-01, Vol.65, p.450-461

2018

Volltextzugriff (PDF)

Synthesis and Evaluation of Antimicrobial Activity of [R₄W₄K]-Levofloxacin and [R₄W₄K]-Levofloxacin-Q Conjugates

Molecules (Basel, Switzerland), 2017-06, Vol.22 (6), p.957

2017

Volltextzugriff (PDF)

Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections

Biomaterials, 2016-09, Vol.101, p.207-216

2016

Volltextzugriff (PDF)

Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization

Colloids and surfaces, B, Biointerfaces, 2016-07, Vol.143, p.168-176

2016

Volltextzugriff (PDF)

The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.427-436

2015

Volltextzugriff (PDF)

Synergistic Effects of Anionic/Cationic Dendrimers and Levofloxacin on Antibacterial Activities

Molecules (Basel, Switzerland), 2019-08, Vol.24 (16), p.2894

2019

Volltextzugriff (PDF)

Study on the Mechanism of Levofloxacin Combined with Imipenem Against Pseudomonas aeruginosa

Applied biochemistry and biotechnology, 2024-02, Vol.196 (2), p.690-700

2024

Volltextzugriff (PDF)

New Organic Salt from Levofloxacin-Citric Acid: What Is the Impact on the Stability and Antibiotic Potency?

Molecules (Basel, Switzerland), 2022-03, Vol.27 (7), p.2166

2022

Volltextzugriff (PDF)

Oxidative transformation of levofloxacin by δ-MnO2: Products, pathways and toxicity assessment

Chemosphere (Oxford), 2015-01, Vol.119, p.282-288

2015

Volltextzugriff (PDF)

Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study

Molecular pharmaceutics, 2019-05, Vol.16 (5), p.1906-1916

2019

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB

Journal of antimicrobial chemotherapy, 2016-10, Vol.71 (10), p.2691-2703

2016

Volltextzugriff (PDF)

Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens

Bioorganic & medicinal chemistry letters, 2015-09, Vol.25 (18), p.3928-3932

2015

Volltextzugriff (PDF)

Effect of silver nanoparticles on the antibacterial activity of Levofloxacin against methicillin-resistant Staphylococcus aureus

European review for medical and pharmacological sciences, 2021-09, Vol.25 (17), p.5507

Saadh, M J

2021

Volltextzugriff (PDF)

Assessment the efficacy of some various treatment methods, in vitro and in vivo, against Aeromonas hydrophila infection in fish with regard to side effects and residues

Comparative biochemistry and physiology. Toxicology & pharmacology, 2022-03, Vol.253, p.109246-109246, Article 109246

2022

Volltextzugriff (PDF)

Synergistic effect of chlorogenic acid and levofloxacin against Klebsiella pneumonia infection in vitro and in vivo

Scientific reports, 2020-11, Vol.10 (1), p.20013, Article 20013

2020

Volltextzugriff (PDF)

Chitosan-coated liposome with lysozyme-responsive properties for on-demand release of levofloxacin

International journal of biological macromolecules, 2024-06, Vol.269 (Pt 2), p.132271-132271, Article 132271

2024

Volltextzugriff (PDF)

Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment

International journal of pharmaceutics, 2024-07, Vol.660, p.124309, Article 124309

2024

Volltextzugriff (PDF)

Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial

Journal of microbiology, immunology and infection, 2019-02, Vol.52 (1), p.35-44

2019

Volltextzugriff (PDF)

Self-assembly of amino acid-based random copolymers for antibacterial application and infection treatment as nanocarriers

Journal of colloid and interface science, 2019-03, Vol.540, p.634-646

2019

Volltextzugriff (PDF)

Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis

The American journal of gastroenterology, 2022-08, Vol.117 (8), p.1221-1230

2022

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

Prevalence of Helicobacter pylori resistance to certain antibiotics at An-Najah University Hospital: a cross-sectional study

Scientific reports, 2024-06, Vol.14 (1), p.14542-6, Article 14542

2024

Volltextzugriff (PDF)

Mesoporous Bioactive Glasses Equipped with Stimuli‐Responsive Molecular Gates for Controlled Delivery of Levofloxacin against Bacteria

Chemistry : a European journal, 2018-12, Vol.24 (71), p.18944-18951

2018

Volltextzugriff (PDF)

Levofloxacin and indolicidin for combination antimicrobial therapy

Current drug delivery, 2015-01, Vol.12 (1), p.108-114

2015

Volltextzugriff (PDF)

1 – 25 von 1.135

Suche als RSS-Feed

Aktive Filter

ThemaAnti-Bacterial Agents - Pharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.098)
Mit Volltextzugriff
(1.001)

Publikationsform

Artikel
(1.134)
Buchkapitel
(1)

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.020)
Life Sciences & Biomedicine
(946)
Levofloxacin
(915)
Humans
(842)
Microbial Sensitivity Tests
(749)
Microbiology
(592)
Infectious Diseases
(409)
Pharmacology & Pharmacy
(409)
Ofloxacin - Pharmacology
(407)
Antibiotics
(362)
Levofloxacin - Pharmacology
(359)
Biological And Medical Sciences
(295)
Drug Resistance, Bacterial
(294)
Medical Sciences
(277)
Male
(269)
Female
(262)
Drug Resistance
(253)
Anti-Bacterial Agents - Therapeutic Use
(244)
Pharmacology. Drug Treatments
(239)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties

Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection

Synthesis and Evaluation of Antimicrobial Activity of [R₄W₄K]-Levofloxacin and [R₄W₄K]-Levofloxacin-Q Conjugates

Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections

Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization

The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility

Synergistic Effects of Anionic/Cationic Dendrimers and Levofloxacin on Antibacterial Activities

Study on the Mechanism of Levofloxacin Combined with Imipenem Against Pseudomonas aeruginosa

New Organic Salt from Levofloxacin-Citric Acid: What Is the Impact on the Stability and Antibiotic Potency?

Oxidative transformation of levofloxacin by δ-MnO2: Products, pathways and toxicity assessment

Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB

Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens

Effect of silver nanoparticles on the antibacterial activity of Levofloxacin against methicillin-resistant Staphylococcus aureus

Assessment the efficacy of some various treatment methods, in vitro and in vivo, against Aeromonas hydrophila infection in fish with regard to side effects and residues

Synergistic effect of chlorogenic acid and levofloxacin against Klebsiella pneumonia infection in vitro and in vivo

Chitosan-coated liposome with lysozyme-responsive properties for on-demand release of levofloxacin

Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment

Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial

Self-assembly of amino acid-based random copolymers for antibacterial application and infection treatment as nanocarriers

Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis

Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function

Prevalence of Helicobacter pylori resistance to certain antibiotics at An-Najah University Hospital: a cross-sectional study

Mesoporous Bioactive Glasses Equipped with Stimuli‐Responsive Molecular Gates for Controlled Delivery of Levofloxacin against Bacteria

Levofloxacin and indolicidin for combination antimicrobial therapy

Aktive Filter

Suchergebnisse filtern